Episode 68: Dr. R.V. Paul Chan discusses Retinopathy of Prematurity
Dr. R.V. Paul Chan of the Illinois Eye and Ear Infirmary joins the program to discuss retinopathy of prematurity (ROP) including a review of basic terminology, updates of medical advances and the role of anti-VEGF drugs, and the role of telemedicine in the future of ROP worldwide.
##### Thanks to @Mike Venincasa for Episode Outline and @Louie Cai for Episode Production #####
[1:30] How did you decide to be an ophthalmologist?
[2:48] Was retina something high on your priority list going into ophthalmology?
[5:58] How did you move from general retina to pediatric retina and ROP?
[7:55] Can you quickly review the basics of ROP?
[11:50] How do you incorporate anti-VEGF into your practice, and how do you see its future role in management?
[15:20] What advice would you have for newly-graduated retina fellows going into practice who encounter pediatric patients who may require surgery?
[17:55] Where are we in terms of telemedicine for ROP, and what kind of future advances or challenges do you foresee?
[20:15] What is the global burden of ROP? Do you think it is something underreported because of access?
[21:40] How have your mentors/mentees affected your decision for an academic career?
[23:55] A lot of fellows feel like their first job will be their last job, but you just switched jobs. Any thoughts on this?
You can find this episode and all prior episodes on our website (Retinapodcast.com).